发明申请
US20130203805A1 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
审中-公开
使用缺氧诱导因子（HIF）羟化酶抑制剂治疗贫血的方法
- 专利标题： Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
- 专利标题（中）： 使用缺氧诱导因子（HIF）羟化酶抑制剂治疗贫血的方法
-
申请号： US13614917申请日： 2012-09-13
-
公开(公告)号： US20130203805A1公开(公告)日： 2013-08-08
- 发明人: Stephen J. Klaus , Al Y. Lin , Thomas B. Neff , Qingjian Wang , Volkmar Guenzler-Pukall , Michael P. Arend , Lee A. Flippin , Alex Melekhov
- 申请人： Stephen J. Klaus , Al Y. Lin , Thomas B. Neff , Qingjian Wang , Volkmar Guenzler-Pukall , Michael P. Arend , Lee A. Flippin , Alex Melekhov
- 申请人地址： US CA San Francisco
- 专利权人： FIBROGEN, INC.
- 当前专利权人： FIBROGEN, INC.
- 当前专利权人地址： US CA San Francisco
- 主分类号： A61K31/472
- IPC分类号： A61K31/472 ; A61K31/47
摘要：
The present invention relates to methods for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. Methods for treating, pretreating or preconditioning, or preventing erythropoietin-associated conditions are also included. Compounds for use in these methods are provided, as are methods of identifying such compounds.
信息查询
IPC分类:
